These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29686668)

  • 1. Emerging Concepts of Adaptive Immunity in Leprosy.
    Sadhu S; Mitra DK
    Front Immunol; 2018; 9():604. PubMed ID: 29686668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.
    Sadhu S; Khaitan BK; Joshi B; Sengupta U; Nautiyal AK; Mitra DK
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004338. PubMed ID: 26751584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypothetical role for Notch signaling pathway in immunopathogenesis of leprosy.
    Serrano-Coll H; Acevedo-Saenz L; Cardona-Castro N
    Med Hypotheses; 2017 Nov; 109():162-169. PubMed ID: 29150278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
    Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
    BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fate of T Cells and their Secretory Proteins During the Progression of Leprosy.
    Tarique M; Saini C; Naz H; Naqvi RA; Khan FI; Sharma A
    Curr Protein Pept Sci; 2018; 19(9):889-899. PubMed ID: 28847289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T helper cells in leprosy: An update.
    Saini C; Tarique M; Rai R; Siddiqui A; Khanna N; Sharma A
    Immunol Lett; 2017 Apr; 184():61-66. PubMed ID: 28235552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy.
    Fonseca AB; Simon MD; Cazzaniga RA; de Moura TR; de Almeida RP; Duthie MS; Reed SG; de Jesus AR
    Infect Dis Poverty; 2017 Feb; 6(1):5. PubMed ID: 28162092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
    Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
    Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.
    Santos MB; de Oliveira DT; Cazzaniga RA; Varjão CS; Dos Santos PL; Santos MLB; Correia CB; Faria DR; Simon MDV; Silva JS; Dutra WO; Reed SG; Duthie MS; de Almeida RP; de Jesus AR
    Scand J Immunol; 2017 Jul; 86(1):40-49. PubMed ID: 28426172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.
    García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA
    J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ Th17 cells discriminate clinical types and constitute a third subset of non Th1, Non Th2 T cells in human leprosy.
    Saini C; Ramesh V; Nath I
    PLoS Negl Trop Dis; 2013; 7(7):e2338. PubMed ID: 23936569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of leprosy and diagnostic challenges.
    Nath I; Saini C; Valluri VL
    Clin Dermatol; 2015; 33(1):90-8. PubMed ID: 25432814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.
    Misra N; Murtaza A; Walker B; Narayan NP; Misra RS; Ramesh V; Singh S; Colston MJ; Nath I
    Immunology; 1995 Sep; 86(1):97-103. PubMed ID: 7590888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions.
    Costa MB; Hungria EM; Freitas AA; Sousa ALOM; Jampietro J; Soares FA; Stefani MMA
    PLoS One; 2018; 13(6):e0196853. PubMed ID: 29883464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin Deficiency May Influence the Divergence of Cell-Mediated Immunity Between Lepromatous and Tuberculoid Leprosy Patients.
    Degechisa ST; Dabi YT
    J Inflamm Res; 2022; 15():6719-6728. PubMed ID: 36536644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of leprosy.
    Froes LAR; Trindade MAB; Sotto MN
    Int Rev Immunol; 2022; 41(2):72-83. PubMed ID: 33241709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.